SSL7_STAAE
ID SSL7_STAAE Reviewed; 231 AA.
AC A0A0H3K6Z8;
DT 03-JUL-2019, integrated into UniProtKB/Swiss-Prot.
DT 16-SEP-2015, sequence version 1.
DT 25-MAY-2022, entry version 31.
DE RecName: Full=Staphylococcal superantigen-like 7 {ECO:0000303|PubMed:23797068};
DE Flags: Precursor;
GN Name=ssl7 {ECO:0000303|PubMed:23797068}; OrderedLocusNames=NWMN_0394;
OS Staphylococcus aureus (strain Newman).
OC Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC Staphylococcus.
OX NCBI_TaxID=426430;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=Newman;
RX PubMed=17951380; DOI=10.1128/jb.01000-07;
RA Baba T., Bae T., Schneewind O., Takeuchi F., Hiramatsu K.;
RT "Genome sequence of Staphylococcus aureus strain Newman and comparative
RT analysis of staphylococcal genomes: polymorphism and evolution of two major
RT pathogenicity islands.";
RL J. Bacteriol. 190:300-310(2008).
RN [2]
RP FUNCTION, AND INTERACTION WITH COMPLEMENT C5 AND IGA.
RC STRAIN=Newman;
RX PubMed=23797068; DOI=10.1038/icb.2013.28;
RA Lorenz N., Clow F., Radcliff F.J., Fraser J.D.;
RT "Full functional activity of SSL7 requires binding of both complement C5
RT and IgA.";
RL Immunol. Cell Biol. 91:469-476(2013).
RN [3]
RP X-RAY CRYSTALLOGRAPHY (4.20 ANGSTROMS) OF 129-231, FUNCTION, AND
RP INTERACTION WITH COMPLEMENT C5 AND IGA.
RX PubMed=20133685; DOI=10.1073/pnas.0910565107;
RA Laursen N.S., Gordon N., Hermans S., Lorenz N., Jackson N., Wines B.,
RA Spillner E., Christensen J.B., Jensen M., Fredslund F., Bjerre M.,
RA Sottrup-Jensen L., Fraser J.D., Andersen G.R.;
RT "Structural basis for inhibition of complement C5 by the SSL7 protein from
RT Staphylococcus aureus.";
RL Proc. Natl. Acad. Sci. U.S.A. 107:3681-3686(2010).
CC -!- FUNCTION: Plays a role in the inhibition of host complement-mediated
CC lysis and serum bactericidal activity by interacting with complement
CC component C5 (PubMed:23797068). Affects all three pathways of
CC complement activation and inhibits the cleavage of C5 by preventing its
CC binding to C5 convertases. In turn, prevents C5a-mediated neutrophil
CC migration (By similarity). {ECO:0000250|UniProtKB:Q2G2Y0,
CC ECO:0000269|PubMed:23797068}.
CC -!- SUBUNIT: Interacts with host IgA and complement C5.
CC {ECO:0000269|PubMed:20133685, ECO:0000269|PubMed:23797068}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q2G1S8}.
CC -!- SIMILARITY: Belongs to the staphylococcal/streptococcal toxin family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AP009351; BAF66666.1; -; Genomic_DNA.
DR RefSeq; WP_000769836.1; NZ_CP023390.1.
DR PDB; 3KM9; X-ray; 4.20 A; X/Y=129-231.
DR PDBsum; 3KM9; -.
DR AlphaFoldDB; A0A0H3K6Z8; -.
DR SMR; A0A0H3K6Z8; -.
DR EnsemblBacteria; BAF66666; BAF66666; NWMN_0394.
DR KEGG; sae:NWMN_0394; -.
DR HOGENOM; CLU_054950_1_0_9; -.
DR OMA; GQNHQLF; -.
DR Proteomes; UP000006386; Chromosome.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR InterPro; IPR008992; Enterotoxin.
DR InterPro; IPR015282; SSL_OB.
DR InterPro; IPR006126; Staph/Strept_toxin_CS.
DR InterPro; IPR008375; Staph_exotoxin.
DR InterPro; IPR016091; SuperAg_toxin_C.
DR InterPro; IPR013307; Superantigen_bac.
DR InterPro; IPR006123; Toxin_b-grasp_Staph/Strep.
DR Pfam; PF09199; SSL_OB; 1.
DR Pfam; PF02876; Stap_Strp_tox_C; 1.
DR PRINTS; PR01898; SAGSUPRFAMLY.
DR PRINTS; PR01800; STAPHEXOTOXN.
DR PRINTS; PR01501; TOXICSSTOXIN.
DR SUPFAM; SSF50203; SSF50203; 1.
DR SUPFAM; SSF54334; SSF54334; 1.
DR PROSITE; PS00278; STAPH_STREP_TOXIN_2; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Secreted; Signal; Virulence.
FT SIGNAL 1..30
FT /evidence="ECO:0000255"
FT CHAIN 31..231
FT /note="Staphylococcal superantigen-like 7"
FT /id="PRO_0000447560"
SQ SEQUENCE 231 AA; 26168 MW; 8B9F437C0BB33E66 CRC64;
MKLKTLAKAT LALGLLTTGV ITSEGQAVQA KEKQERVQHL YDIKDLHRYY SSESFEFSNI
SGKVENYNGS NVVRFNQENQ NHQLFLLGKD KEKYKEGIEG KDVFVVKELI DPNGRLSTVG
GVTKKNNKSS ETNTHLFVNK VYGGNLDASI DSFSINKEEV SLKELDFKIR QHLVKNYGLY
KGTTKYGKIT INLKDGEKQE IDLGDKLQFE RMGDVLNSKD INKIEVTLKQ I